Dainippon Pharmaceutical Company, Limited

Dainippon Sumitomo Pharma Co., Ltd.

Yoshimi Hirokawa

Shiro Kato

Naoyuki Yoshida

Hiroshi Harada

Hiroshi Yamazaki

Toshiya Morie

Yoko Kan

Hitoshi Kawashima

Takanori Nakamura

Yukiko Morikage

Kazuo Morikage

Disclosed is a compound having a strong affinity to serotonin-4 receptors, which is useful as an enterokinesis-promoting agent or a digestive tract function-improving agent. Specifically, disclosed is a compound represented by Formula (1) or a pharmaceutically acceptable salt thereof. Also specifically disclosed is a pharmaceutical composition containing a compound represented by Formula (1) or a pharmaceutically acceptable salt thereof. [In Formula (1), Ar represents a group represented by Formula (Ar-1) or Formula (Ar-2).] 

Amide derivative and pharmaceutical composition containing the same

(S)-4-AMINO-5-CHLORO-2-METHOXY-N-&lsqb;1-&lsqb;1-(2-TETRAHYDROFURYL-CARBONYL)-4-PIPERIDINYLMETHYL&rsqb;-4-PIPERIDINYL&rsqb;BENZAMIDE, PROCESS FOR THE PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND INTERMEDIATE THEREFOR

(R)-5-bromo-N-(1-ethyl-4-methylhexahydr

6-methoxy-1H-benzotriazole-5-carboxamide derivatives and pharmaceutical

Indole derivatives having a 2-phenyl-ethanolamino-substituted lower

Growing community of inventors

Ikoma, Japan

Yoshimi Hirokawa